MEDICINOVA INC (MNOV) › Cash & EquivalentsMEDICINOVA INC (MNOV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $19.30M2009: $19.24M2010: $28.25M2011: $15.09M2012: $4.01M2013: $6.70M2014: $11.67M2015: $22.08M2016: $24.12M2017: $27.99M2018: $62.31M2019: $63.79M2020: $60.04M2021: $71.43M2022: $18.51M2023: $51.00M2024: $40.36M2025: $30.81M$30.81M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$30.81M-23.7%2024$40.36M-20.9%2023$51.00M+175.6%2022$18.51M-74.1%2021$71.43M+19.0%2020$60.04M-5.9%2019$63.79M+2.4%2018$62.31M+122.6%2017$27.99M+16.1%2016$24.12M+9.2%2015$22.08M+89.2%2014$11.67M+74.2%2013$6.70M+67.1%2012$4.01M-73.4%2011$15.09M-46.6%2010$28.25M+46.8%2009$19.24M-0.3%2008$19.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share